Health Care [ 9/12 ] | Pharmaceuticals [ 55/74 ]
NASDAQ | Common Stock
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.
The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain.
It also develops BAER-101 for the treatment of epilepsy and panic disorders.
The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida.
Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 11, 24 | -1.92 Decreased by -3.30 K% | -0.94 Decreased by -104.26% |
| Aug 9, 24 | -6.43 Decreased by -1.14 K% | -1.05 Decreased by -512.38% |
| May 15, 24 | -15.40 Decreased by -1.04 K% | -9.00 Decreased by -71.11% |
| Mar 18, 24 | 0.06 Increased by +108.00% | -0.10 Increased by +160.00% |
| Nov 13, 23 | 0.06 Increased by +113.28% | -0.26 Increased by +123.08% |
| Aug 10, 23 | -0.52 Decreased by -1.63 K% | -0.29 Decreased by -79.31% |
| May 12, 23 | -1.35 Decreased by -2.60 K% | -0.13 Decreased by -938.46% |
| Mar 31, 23 | -0.75 Decreased by -1.40 K% | -0.15 Decreased by -400.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by N/A% | -1.54 M Decreased by -341.25% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -3.08 M Decreased by -684.79% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -7.19 M Decreased by -79.34% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -4.34 M Increased by +50.17% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | 640.00 K Decreased by -87.24% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | 526.00 K Increased by +179.70% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.01 M Decreased by -564.51% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -8.71 M Decreased by -204.83% | Decreased by N/A% Decreased by N/A% |